These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8119225)

  • 1. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Bonelli L
    Endoscopy; 1993 Nov; 25(9):652-4. PubMed ID: 8119225
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic features of Barrett's esophagus. G.O.S.P.E. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Conio M
    Endoscopy; 1993 Nov; 25(9):642-4. PubMed ID: 8119222
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of proliferating cell nuclear antigen expression in dysplastic intestinal type Barrett's esophagus. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Lapertosa G; Baracchini P; Fulcheri E
    Pathologica; 1994 Apr; 86(2):174-9. PubMed ID: 7936762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori in Barrett's oesophagus. Gruppo Operativo per lo Studio Delle Precancerosi Esofagee (GOSPE)--Precancerous Lesions of the Oesophagus Task Force, Italy.
    Histopathology; 1991 Jun; 18(6):568-70. PubMed ID: 1879820
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE).
    Ferraris R; Bonelli L; Conio M; Fracchia M; Lapertosa G; Aste H
    Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):881-5. PubMed ID: 9355787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus: epidemiological and clinical results of a multicentric survey. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE).
    Int J Cancer; 1991 May; 48(3):364-8. PubMed ID: 2040529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic surveillance of Barrett's esophagus: another viewpoint.
    Richter JE
    Am J Gastroenterol; 1993 May; 88(5):630-2. PubMed ID: 8480722
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenocarcinoma and Barrett's esophagus. An overrated risk?
    Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
    Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Barrett esophagus: epidemiologic data and risk of becoming malignant].
    García Marcilla JA; Parrilla Paricio P; Ortiz Escandell MA; Martínez de Haro LF; Aguado Albasini JL; Molina Martínez J; Rodríguez Bermejo M
    Rev Esp Enferm Apar Dig; 1989 Nov; 76(5):419-23. PubMed ID: 2694239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of high-grade dysplasia in Barrett's esophagus.
    Rice TW; Falk GW; Achkar E; Petras RE
    Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M; Schubert B; Lang-Schwarz K; Stolte M
    Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
    Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
    Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Barrett's esophagus.
    Cameron AJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D3-4. PubMed ID: 8013779
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of adenocarcinoma in Barrett's oesophagus: population based study.
    Murray L; Watson P; Johnston B; Sloan J; Mainie IM; Gavin A
    BMJ; 2003 Sep; 327(7414):534-5. PubMed ID: 12958113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.